Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom

20260 citationsJournal Articlegold Open Access

Authors

Axel Heinze · Christian-Albrechts-Universität zu Kiel

Shazia Afridi · Guy's and St Thomas' NHS Foundation Trust

Todor Totev · Analysis Group (United States)

Lynda J. Krasenbaum · Teva Pharmaceuticals (United States)

Emi Terasawa · Analysis Group (United States)

Hasan Akcicek · Teva Pharmaceuticals (Netherlands)

Joachim Hipp

Abstract

Fremanezumab demonstrated real-world clinical effectiveness in German and UK cohorts and may decrease the burden of migraine for patients and providers.

Topics & Keywords

Migraine and Headache Studies Neurological Complications and Syndromes Cerebrovascular and genetic disorders

Publication Details

Published in: Therapeutics and Clinical Risk Management

Volume Volume 22, pp. 1-16

DOI: 10.2147/tcrm.s529550

Field-Weighted Citation Impact: 0.00

Command Palette

Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom

Authors

Abstract

Topics & Keywords

Publication Details